Page last updated: 2024-08-22

misonidazole and Sarcoma

misonidazole has been researched along with Sarcoma in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19903 (33.33)18.7374
1990's2 (22.22)18.2507
2000's2 (22.22)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, CH; Chang, CW; Chang, TJ; Chou, TK; Lin, WJ; Liu, RS; Wang, HE; Wang, SJ; Wu, CY1
Bentzen, L; Buus, S; Keiding, S; Mortensen, LS; Munk, OL; Nordsmark, M; Overgaard, J1
Conrad, EU; Eary, JF; Krohn, KA; Link, JM; Mankoff, DA; Muzi, M; White, JK1
Hicks, RJ; Toner, GC1
Brown, JM; Kim, IH; Lemmon, MJ1
Bataini, JP; Bernier, J; Brugère, J; Brunin, F; de Narbonne, J; Jaulerry, C1
Adams, GE; Bedwell, J; Bown, SG; Bremner, JC; MacRobert, AJ; Pearson, JK; Phillips, D; Sansom, JM; Stratford, IJ1
Glatstein, E; Kinsella, TJ1
Alliet, K; Maddison, K; Siemann, DW; Wolf, K1

Reviews

1 review(s) available for misonidazole and Sarcoma

ArticleYear
PET for sarcomas other than gastrointestinal stromal tumors.
    The oncologist, 2008, Volume: 13 Suppl 2

    Topics: Biopsy; Dideoxynucleosides; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Misonidazole; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiopharmaceuticals; Sarcoma; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome

2008

Trials

1 trial(s) available for misonidazole and Sarcoma

ArticleYear
[Clinical testing of the radiosensitizer RO-07-0582 (misonidazole). Dose tolerance, toxicity and pharmacokinetic studies, preliminary report (author's transl)].
    Bulletin du cancer, 1978, Volume: 65, Issue:4

    Topics: Bone Neoplasms; Clinical Trials as Topic; Glioma; Humans; Kinetics; Misonidazole; Neoplasms; Nitroimidazoles; Otorhinolaryngologic Diseases; Sarcoma

1978

Other Studies

7 other study(ies) available for misonidazole and Sarcoma

ArticleYear
Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model.
    Nuclear medicine and biology, 2009, Volume: 36, Issue:3

    Topics: Animals; Autoradiography; Cell Line, Tumor; Diagnosis, Differential; Disease Models, Animal; Fluoroacetates; Fluorodeoxyglucose F18; Inflammation; Male; Mice; Misonidazole; Positron-Emission Tomography; Radioactive Tracers; Sarcoma; Tissue Distribution

2009
Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode.
    Acta oncologica (Stockholm, Sweden), 2010, Volume: 49, Issue:7

    Topics: Biosensing Techniques; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Hypoxia; Microchemistry; Microelectrodes; Misonidazole; Neoplasms; Oxygen; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms

2010
Multiagent PET for risk characterization in sarcoma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:4

    Topics: Carbon Dioxide; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Isotope Labeling; Misonidazole; Positron-Emission Tomography; Radiopharmaceuticals; Risk Assessment; Sarcoma; Thymidine; Verapamil

2011
The influence of irradiation of the tumor bed on tumor hypoxia: measurements by radiation response, oxygen electrodes, and nitroimidazole binding.
    Radiation research, 1993, Volume: 135, Issue:3

    Topics: Animals; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Oxygen; Partial Pressure; Sarcoma; Tumor Cells, Cultured

1993
Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145.
    British journal of cancer, 1992, Volume: 66, Issue:6

    Topics: Animals; Indoles; Mice; Misonidazole; Nitroimidazoles; Organometallic Compounds; Photochemotherapy; Sarcoma; Tumor Cells, Cultured

1992
Clinical experience with intravenous radiosensitizers in unresectable sarcomas.
    Cancer, 1987, Mar-01, Volume: 59, Issue:5

    Topics: Adolescent; Adult; Aged; Bone and Bones; Bone Neoplasms; Bromodeoxyuridine; Female; Humans; Injections, Intravenous; Male; Middle Aged; Misonidazole; Radiation Dosage; Radiation-Sensitizing Agents; Sarcoma

1987
Enhancement of the antitumor efficacy of lomustine by the radiosensitizer RSU 1069.
    Cancer treatment reports, 1985, Volume: 69, Issue:12

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Female; Lethal Dose 50; Lomustine; Mice; Mice, Inbred C3H; Misonidazole; Radiation-Protective Agents; Sarcoma

1985